Histological phenotypic subtypes predict recurrence risk and response to adjuvant chemotherapy in patients with stage III colorectal cancer

Histological ‘phenotypic subtypes’ that classify patients into four groups (immune, canonical, latent and stromal) have previously been demonstrated to stratify survival in a stage I–III colorectal cancer (CRC) pilot cohort. However, clinical utility has not yet been validated. Therefore, this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Roseweir, Antonia K, Park, James H, Hoorn, Sanne ten, Powell, Arfon GMT, Aherne, Susan, Roxburgh, Campbell SD, McMillan, Donald C, Horgan, Paul G, Ryan, Elizabeth, Sheahan, Kieran, Vermeulen, Louis, Paul, James, Harkin, Andrea, Graham, Janet, Sansom, Owen, Church, David N, Tomlinson, Ian, Saunders, Mark, Iveson, Tim J, Edwards, Joanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578335/
https://www.ncbi.nlm.nih.gov/pubmed/32401426
http://dx.doi.org/10.1002/cjp2.171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578335/
https://www.ncbi.nlm.nih.gov/pubmed/32401426
http://dx.doi.org/10.1002/cjp2.171

Ejemplares similares